Federal Register / Vol. 66, No. 41 / Thursday, March 1, 2001 / Notices 12937

activities to collect and analyze optional

data consistent with the Program

Requirements for Part B, including

sampling methods and proposed

staffing.

3. Budget and Justification: (Not Scored)

The extent to which the budget is

reasonable, clearly justified, and

consistent with stated objectives and

proposed activities.

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus 2

copies of:

1. Semi-annual progress reports.

2. Financial status report, no more

than 90 days after the end of the budget

period.

3. Final financial and performance

reports, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

For descriptions of the following

Other Requirements, see Attachment I

in the application package:

AR–7—Executive Order 12372 Review

AR–9—Paperwork Reduction Act

Requirements

AR–10—Smoke-Free Workplace

Requirements

AR–11—Healthy People 2010

AR–12—Lobbying Restrictions

AR–13—Prohibition on Use of CDC

Funds for Certain Gun Control

Activities

AR–21—Small, Minority, and WomenOwned Businesses

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

sections 301(a), 317(k)(2), 391, 392,

393A, 394, and 394A [42 U.S.C. 241(a),

247b(k)(2), 280b, 280b–1, 280b–2, 280b–

3] of the Public Health Service Act, as

amended. The Catalog of Federal

Domestic Assistance number is 93.136.

J. Where To Obtain Additional

Information

This and other CDC announcements

are available through the CDC home

page on the Internet at: http://

www.cdc.gov. To receive additional

written information and to request an

application kit, call 1–888–GRANTS4

(1–888 472–6874). You will be asked to

leave your name and address, and will

be instructed to identify the

announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management assistance may be

obtained from: Angie Nation, Grants

Management Specialist, Announcement

#01030, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Suite 3000,

Atlanta, GA 30341–4146, Telephone

number (770) 488–2719, Email address:

aen4@cdc.gov.

For program technical assistance,

contact: Renee Johnson, MSPH, CDC

National Center for Injury Prevention

and Control, 4770 Buford Highway, NE,

Mailstop F41, Atlanta, GA 30341–3724,

Telephone (770) 488–4031, Email

address: nba7@cdc.gov.

For a copy of the CDC Guidelines for

Central Nervous System Injury

Surveillance, contact: Patricia Allen,

CDC National Center for Injury

Prevention and Control, 4770 Buford

Highway, NE, Mailstop F41, Atlanta, GA

30341–3724, Telephone (770) 488–4031,

Email address: pca9@cdc.gov.

CDC does not guarantee to accept or

justify its nonacceptance of

recommendations that are received

more than 60 days after the application

deadline.

Dated: February 23, 2001.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–4937 Filed 2–28–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: Study of the TANF Application

Process.

OMB No. New Collection.

Description: The Study of the TANF

Application Process is designed to

provide systematic information about

how application policies and processes

have changed under TANF, and how

States define and count applications

and application results. The Study will

also explore how application polices are

implemented in a sample of local TANF

offices and will collect data on

individuals’ application decisions,

experiences, and outcomes. In addition,

the Study will also collect information

on the availability and quality of Statecollected data on the TANF application

process. The primary purpose of this

Study is to provide useful information

to be considered in the upcoming TANF

reauthorization process.

Respondents: The respondents for the

Mail Questionnaire are the 50 States, the

District of Columbia, and the U.S.

Territories of Guam, Puerto Rico, and

the Virgin Islands. Eighteen States will

be respondents to the State Telephone

Survey, 54 individuals for the Openended Interviews for Case Studies, six

States for Case Abstractions, and 1200

individuals for the follow-up Telephone

Interviews with Applicants and Nonapplicants.

ANNUAL BURDEN ESTIMATES

Instrument Number of

Respondents

Number of

Responses

per

Respondent

Average

Burden

Hours per

Response

Total

Burden

Hours

18-State Telephone Survey ............................................................................. 18 1 3 54

54-State Mail Questionaire .............................................................................. 54 1 6 324

Open-ended interview for Case Studies .......................................................... 54 1 1.5 81

Follow-up Telephone Interview with Applicants and Non-applicants .............. 1200 1 .33 396

Case abstractions—pulling case files for contractor review and abstraction .. 6 1 20 120

Estimated Total Annual Burden Hours: .................................................... 975

12938 Federal Register / Vol. 66, No. 41 / Thursday, March 1, 2001 / Notices

In compliance with the requirements

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Administration for Children and

Families is soliciting public comment

on the specific aspects of the

information collection described above.

Copies of the proposed collection of

information can be obtained and

comments may be forwarded by writing

to the Administration for Children and

Families, Office of Information Services,

370 L’Enfant Promenade, SW.,

Washington, DC 20447, Attn: ACF.

Reports Clearance Officer. All

requests should be identified by the title

of the information collection.

The Department specifically requests

comments on: (a) Whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

the quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

Consideration will be given to

comments and suggestions submitted

within 60 days of this publication.

Dated: February 26, 2001.

Bob Sargis,

Reports Clearance Officer.

[FR Doc. 01–5009 Filed 2–28–01; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N–1435]

Agency Information Collection

Activities; Announcement of OMB

Approval; Substantial Evidence of

Effectiveness of New Animal Drugs

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Substantial Evidence of Effectiveness

of New Animal Drugs’’ has been

approved by the Office of Management

and Budget (OMB) under the Paperwork

Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Denver Presley, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1472.

SUPPLEMENTARY INFORMATION: In the

Federal Register of August 16, 2000 (65

FR 49989), the agency announced that

the proposed information collection had

been submitted to OMB for review and

clearance under 44 U.S.C. 3507. An

agency may not conduct or sponsor, and

a person is not required to respond to,

a collection of information unless it

displays a currently valid OMB control

number. OMB has now approved the

information collection and has assigned

OMB control number 0910–0356. The

approval expires on February 29, 2004.

A copy of the supporting statement for

this information collection is available

on the Internet at http://www.fda.gov/

ohrms/dockets.

Dated: February 22, 2001.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 01–4961 Filed 2–28–01; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 95N–0220]

Agency Information Collection

Activities; Announcement of OMB

Approval; Substances Approved for

Use in the Preparation of Meat and

Poultry Products

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Substances Approved for Use in the

Preparation of Meat and Poultry

Products’’ has been approved by the

Office of Management and Budget

(OMB) under the Paperwork Reduction

Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Peggy Schlosburg, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1223.

SUPPLEMENTARY INFORMATION: In the

Federal Register of August 25, 2000 (65

FR 51758), the agency announced that

the proposed information collection had

been submitted to OMB for review and

clearance under 44 U.S.C. 3507. An

agency may not conduct or sponsor, and

a person is not required to respond to,

a collection of information unless it

displays a currently valid OMB control

number. OMB has now approved the

information collection and has assigned

OMB control number 0910–0461. The

approval expires on February 29, 2004.

A copy of the supporting statement for

this information collection is available

on the Internet at http://www.fda.gov/

ohrms/dockets.

Dated: February 22, 2001.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 01–4965 Filed 2–28–01; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N–0242]

Agency Information Collection

Activities; Announcement of OMB

Approval; Biological Products:

Reporting of Biological Product

Deviations in Manufacturing

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Biological Products: Reporting of

Biological Product Deviations in

Manufacturing’’ has been approved by

the Office of Management and Budget

(OMB) under the Paperwork Reduction

Act of 1995.

FOR FURTHER INFORMATION CONTACT:

JonnaLynn P. Capezzuto, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–4659.

SUPPLEMENTARY INFORMATION: In the

Federal Register of November 7, 2000

(65 FR 66621), the agency announced

that the proposed information collection

had been submitted to OMB for review

and clearance under 44 U.S.C. 3507. An

agency may not conduct or sponsor, and

a person is not required to respond to,

a collection of information unless it

displays a currently valid OMB control

number. OMB has now approved the

information collection and has assigned

OMB control number 0910–0458. The

approval expires on February 29, 2004.

A copy of the supporting statement for

this information collection is available

on the Internet at http://www.fda.gov/

ohrms/dockets.